UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3213) 3213
Book Chapter (210) 210
Newsletter (187) 187
Newspaper Article (33) 33
Magazine Article (17) 17
Dissertation (15) 15
Conference Proceeding (5) 5
Publication (4) 4
Government Document (2) 2
Streaming Video (2) 2
Book Review (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
zoledronic acid (3525) 3525
science & technology (2034) 2034
life sciences & biomedicine (1916) 1916
humans (1526) 1526
female (956) 956
male (784) 784
bisphosphonates (769) 769
oncology (769) 769
diphosphonates - therapeutic use (755) 755
osteoporosis (717) 717
imidazoles - therapeutic use (631) 631
bone density conservation agents - therapeutic use (582) 582
middle aged (526) 526
research (524) 524
cancer (510) 510
care and treatment (506) 506
aged (503) 503
animals (501) 501
diphosphonates - pharmacology (484) 484
diphosphonates - administration & dosage (468) 468
metastasis (462) 462
breast cancer (450) 450
bone neoplasms - secondary (443) 443
imidazoles - pharmacology (432) 432
imidazoles - administration & dosage (420) 420
drug therapy (371) 371
prostate cancer (367) 367
denosumab (366) 366
biological and medical sciences (363) 363
diphosphonates - adverse effects (356) 356
bone neoplasms - drug therapy (348) 348
bones (341) 341
medical sciences (339) 339
bone density conservation agents - administration & dosage (338) 338
analysis (332) 332
endocrinology & metabolism (327) 327
fractures (322) 322
bisphosphonate (321) 321
tumors (309) 309
health aspects (297) 297
imidazoles - adverse effects (295) 295
treatment outcome (272) 272
bone density conservation agents - adverse effects (271) 271
medicine & public health (269) 269
risk factors (269) 269
adult (265) 265
acids (251) 251
bone density conservation agents - pharmacology (250) 250
orthopedics (249) 249
bone metastases (243) 243
aged, 80 and over (228) 228
bone mineral density (225) 225
mice (222) 222
patients (222) 222
bone density - drug effects (221) 221
breast neoplasms - pathology (214) 214
clinical trials (213) 213
pharmacology & pharmacy (210) 210
dosage and administration (207) 207
chemotherapy (206) 206
multiple myeloma (206) 206
metastases (196) 196
apoptosis (193) 193
medical research (191) 191
cell line, tumor (189) 189
bone metastasis (188) 188
breast neoplasms - drug therapy (187) 187
pharmacology. drug treatments (182) 182
complications and side effects (179) 179
bone cancer (170) 170
diphosphonates (169) 169
bone density (168) 168
phosphonates (168) 168
osteonecrosis (166) 166
osteoporosis - drug therapy (161) 161
prostatic neoplasms - pathology (161) 161
dentistry (160) 160
pamidronate (159) 159
antineoplastic agents - therapeutic use (158) 158
pain (157) 157
surgery (156) 156
prevention (152) 152
quality of life (152) 152
cancer therapies (151) 151
medicine (149) 149
rats (149) 149
medicine, experimental (146) 146
diseases of the osteoarticular system (142) 142
bone resorption (141) 141
rheumatology (139) 139
postmenopausal women (138) 138
density (136) 136
cell biology (132) 132
apoptosis - drug effects (127) 127
dentistry, oral surgery & medicine (127) 127
prostatic neoplasms - drug therapy (125) 125
research article (125) 125
bone (124) 124
infusions, intravenous (124) 124
antineoplastic agents (122) 122
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3583) 3583
Spanish (34) 34
Portuguese (31) 31
Japanese (29) 29
Chinese (21) 21
Russian (17) 17
German (12) 12
Turkish (11) 11
French (8) 8
Polish (8) 8
Italian (4) 4
Hungarian (3) 3
Korean (3) 3
Czech (2) 2
Dutch (1) 1
Estonian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 1989 - 1999
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | General aspects | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Humans | Middle Aged | Multiple Myeloma - secondary | Bone Neoplasms - secondary | Imidazoles - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Multiple Myeloma - drug therapy | Diphosphonates - therapeutic use | Adult | Female | Imidazoles - therapeutic use | Odds Ratio | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Bone Density Conservation Agents - therapeutic use | Logistic Models | Treatment Outcome | United Kingdom | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Neoplasms - prevention & control | Clodronic Acid - therapeutic use | Aged | Clodronic Acid - administration & dosage | Infusions, Intravenous | Neoplasm Staging | Research Design | Zoledronic acid | Complications and side effects | Dosage and administration | Drug therapy | Patient outcomes | Multiple myeloma | Medical research | Chemotherapy | Radiation therapy | Medical treatment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 15, pp. 1396 - 1405
Journal Article
Journal of bone and mineral research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 503 - 511
ZOLEDRONIC ACID | INFUSION | TERIPARATIDE | BISPHOSPHONATE | OSTEOPOROSIS | Bisphosphonate | teriparatide | infusion | osteoporosis | zoledronic acid | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Vertebrates: osteoarticular system, musculoskeletal system | Skeleton and joints | Collagen Type I - blood | Peptides - blood | Injections, Intravenous | Teriparatide - therapeutic use | Bone Density - physiology | Follow-Up Studies | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Imidazoles - administration & dosage | Osteoporotic Fractures - drug therapy | Bone Remodeling - physiology | Injections, Subcutaneous | Peptide Fragments - blood | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporotic Fractures - physiopathology | Diphosphonates - adverse effects | Biomarkers - metabolism | Bone Density Conservation Agents - adverse effects | Teriparatide - administration & dosage | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Diphosphonates - administration & dosage | Procollagen - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Osteoporotic Fractures - complications | Least-Squares Analysis | Osteoporosis, Postmenopausal - physiopathology | Teriparatide - adverse effects | Aged | Osteoporotic Fractures - blood | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
Journal Article